Chris Jewell
Geen lopende functies
Vermogen: - $ op 30-04-2024
Profiel
Chris Jewell is a Professor at the University of Maryland and the Chief Scientific Officer at Cartesian Therapeutics, Inc. He previously held the position of Chief Scientific Officer at Cartesian Therapeutics, Inc. in 2023.
He earned a doctorate degree from the University of Wisconsin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
-.--% | 18-04-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Chris Jewell
| Bedrijven | Functie | Begin |
|---|---|---|
| University of Maryland | Corporate Officer/Principal | - |
Eerdere bekende functies van Chris Jewell
| Bedrijven | Functie | Einde |
|---|---|---|
Cartesian Therapeutics, Inc.
 Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Hoofd Techniek/Wetenschap/O&O | 13-11-2023 |
Opleiding van Chris Jewell
| University of Wisconsin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Commercial Services |
